Hexamidina; Hexamidinum; UNII-3483C2H13H; CHEMBL25105; 4,4'-(1,6-Hexanediylbis(oxy))bis-benzenecarboximidamide; 3483C2H13H; 4,4'-[hexane-1,6-diylbis(oxy)]dibenzenecarboximidamide; Hexamidinum [INN-Latin]; Hexamidina [INN-Spanish]; CHEMBL494852; Hexamidine [INN:BAN:DCF]; 4-[6-(4-carbamimidoylphenoxy)hexoxy]benzenecarboximidamide; Hexamidine[antipeptic]; Hexamidine (INN/BAN); 4-[6-(4-carbamimidoylphenoxy)hexoxy]benzamidine; SCHEMBL144738; 1,6-Di(4-amidinophenoxy)hexane; DTXSID60191524; 4,4'[1,6-HEXANEDIYLBIS(OXY)]BISBENZENECARBOXIMIDAMIDE; Benzenecarboximidamide, 4,4'-(1,6-hexanediylbis(oxy))bis-; ZINC1705403; BDBM50015234; STL483397; 1,6-Di (4-amidinophenoxy)-n-hexane; DB03808; FT-0700701; FT-0700706; D07206; Q250360; 4-[6-(4-Carbamimidoyl-phenoxy)-hexyloxy]-benzamidine; 4,4'-[hexane-1,6-diylbis(oxy)]di(benzene-1-carboximidamide); 4,4''''[1,6-HEXANEDIYLBIS(OXY)]BISBENZENECARBOXIMIDAMIDE; 4-{6-[4-amino(imino)methylphenoxy]hexyloxy}phenyl-iminomethanamine; 4-{6-[4-ammino(imino)methylphenoxy]hexyloxy}phenyl-iminomethanammine